|
|
|
| Lentiviral Vector Quality Control | As the application of lentiviral (LV) vectors continues to expand, understanding the critical aspects of biosafety testing and quality control becomes paramount. This webinar explores the latest advancements in release testing of LV vectors, focusing on the key requirements for ensuring patient safety and therapeutic efficacy. You will gain insights into the regulatory landscape for performing release testing, including the detection of RCL and the methodology for determining infectious titer. Watch. |
|
|
|
|
By Cell & Gene: The Podcast | Episode 141 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Ali Pashazadeh, Founder, Chairman, and CEO of Treehill Partners, about the manufacturing challenges that continue to limit cell and gene therapy development. | |
|
|
|
| How To Build A Cell Therapy CMC Roadmap | Article | By Bruce Thompson, Ph.D., and Roger Herr, Ph.D., Kincellis | A structured, phase-appropriate regulatory roadmap helps cell therapy developers reduce risk, streamline manufacturing and testing, and avoid costly clinical delays. |
|
|
|
|
| CAR-T Has A Geography Problem | Article | By Michael Kadan, Vector BioMed | Cellular immunotherapies deliver strong clinical results, but centralized manufacturing and complex logistics limit access. Regional, standardized production can expand global patient access. |
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|